Health Canada Authorizes Updated Novavax COVID-19 Vaccine Targeting XBB Variant

A kidney dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use at a vaccination center in Prisdorf, Germany, on Feb. 26, 2022. The Canadian Press/Georg Wendt

Health Canada has authorized an updated COVID-19 vaccine from Novavax that targets the XBB.1.5 variant.

The new vaccine is called Nuvaxovid and is approved for people 12 years of age and over.